Clinical trials of Israeli drug begin in Greece

Greece has begun clinical trials of an Israeli coronavirus treatment at two hospitals. The treatment will be administered to a total of 90 patients suffering from mild or moderate Covid-19 infection at the Sotiria and Attikon hospitals in Athens. Speaking on Mega TV yesterday, Mina Gaga, director of the Sotiria’s 7th Pulmonary Clinic, said that while more clinical trials are needed to test the safety and efficacy of the drug before it goes mainstream, studies in Israel have so far shown great promise. EXO-CD24, developed at Tel Aviv’s Ichilov Medical Center, fights the potentially lethal overreaction of the body’s immune system to Covid-19, which experts say is responsible for many deaths.